Efficacy evaluation and safety analysis of first-line chemotherapy versus chemotherapy combined with PD-1 monoclonal antibody in patients with advanced cholangiocarcinoma

LI Yinglin; YE Sisi; QIAO Qian; BAI Li

doi:10.3969/j.issn.1009-0460.2022.09.006

Home>Articles>Efficacy evaluation and safety analysis of first-line chemotherapy versus chemotherapy combined with PD-1 monoclonal antibody in patients with advanced cholangiocarcinoma

DOI: 10.3969/j.issn.1009-0460.2022.09.006

Efficacy evaluation and safety analysis of first-line chemotherapy versus chemotherapy combined with PD-1 monoclonal antibody in patients with advanced cholangiocarcinoma

LI Yinglin

YE Sisi

QIAO Qian

BAI Li

Machine-generated Keywords：

Publication Date：2022-09-28

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 801-805 )

Chinese Clinical Oncology

ISTICPKU

ISSN：1009-0460

Year, Vol.(Issue)：2022,27(9)